Non-inferiority and Tolerance of Conversion From Prograf(R) to Advagraf(R) at D7 Versus D90 After Liver Transplantation

Trial Profile

Non-inferiority and Tolerance of Conversion From Prograf(R) to Advagraf(R) at D7 Versus D90 After Liver Transplantation

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Dec 2016

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Liver transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Dec 2016 Planned End Date changed from 1 Nov 2016 to 1 Feb 2017.
    • 08 Jun 2016 Status changed from recruiting to active, no longer recruiting.
    • 09 Jun 2015 Planned End Date changed from 1 May 2017 to 1 Nov 2016 as reported by Clinical trials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top